ID   C1QB_MOUSE              Reviewed;         253 AA.
AC   P14106; Q3U793;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   07-APR-2021, entry version 172.
DE   RecName: Full=Complement C1q subcomponent subunit B;
DE   Flags: Precursor;
GN   Name=C1qb;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=ICR; TISSUE=Macrophage;
RX   PubMed=2591537; DOI=10.1016/0014-5793(89)81622-9;
RA   Petry F., Reid K.B.M., Loos M.;
RT   "Molecular cloning and characterization of the complementary DNA coding for
RT   the B-chain of murine Clq.";
RL   FEBS Lett. 258:89-93(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3258283; DOI=10.1016/0165-2478(88)90102-2;
RA   Wood L., Pulaski S., Vogeli G.;
RT   "cDNA clones coding for the complete murine B chain of complement Clq:
RT   nucleotide and derived amino acid sequences.";
RL   Immunol. Lett. 17:59-62(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=BALB/cJ; TISSUE=Liver;
RX   PubMed=8606057; DOI=10.1007/bf02199805;
RA   Petry F., McClive P.J., Botto M., Morley B.J., Morahan G., Loos M.;
RT   "The mouse C1q genes are clustered on chromosome 4 and show conservation of
RT   gene organization.";
RL   Immunogenetics 43:370-376(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   GLYCOSYLATION ON HYDROXYLYSINES.
RX   PubMed=6286235; DOI=10.1016/s0174-173x(81)80015-5;
RA   Yonemasu K., Shinkai H., Sasaki T.;
RT   "Comparable content of hydroxylysine-linked glycosides in subcomponents C1q
RT   of the first component of human, bovine and mouse complement.";
RL   Coll. Relat. Res. 1:385-390(1981).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Liver, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: C1q associates with the proenzymes C1r and C1s to yield C1,
CC       the first component of the serum complement system. The collagen-like
CC       regions of C1q interact with the Ca(2+)-dependent C1r(2)C1s(2)
CC       proenzyme complex, and efficient activation of C1 takes place on
CC       interaction of the globular heads of C1q with the Fc regions of IgG or
CC       IgM antibody present in immune complexes.
CC   -!- SUBUNIT: C1 is a calcium-dependent trimolecular complex of C1q, R and S
CC       in the molar ration of 1:2:2. C1q subcomponent is composed of nine
CC       subunits, six of which are disulfide-linked dimers of the A and B
CC       chains, and three of which are disulfide-linked dimers of the C chain.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Highest expression in thioglycolate-activated
CC       peritoneal macrophages. Also found in spleen, thymus and heart. Very
CC       weak expression liver, kidney, lung and intestine.
CC       {ECO:0000269|PubMed:2591537}.
CC   -!- PTM: Hydroxylated on lysine and proline residues. Hydroxylated lysine
CC       residues can be glycosylated. Mouse C1Q contains up to 64.0
CC       hydroxylysine-galactosylglucose residues. Total percentage
CC       hydroxylysine residues glycosylated is 95.1%. Contains no
CC       hydroxylysine-monosaccharides. {ECO:0000269|PubMed:6286235}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X16874; CAA34757.1; -; mRNA.
DR   EMBL; M36293; AAA37283.1; -; mRNA.
DR   EMBL; M22531; AAA37335.1; -; mRNA.
DR   EMBL; X92959; CAA63534.1; -; Genomic_DNA.
DR   EMBL; AK152764; BAE31477.1; -; mRNA.
DR   EMBL; AL627214; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC067001; AAH67001.1; -; mRNA.
DR   CCDS; CCDS18810.1; -.
DR   PIR; I49560; I49560.
DR   RefSeq; NP_033907.1; NM_009777.2.
DR   SMR; P14106; -.
DR   BioGRID; 198413; 5.
DR   ComplexPortal; CPX-4981; Complement component C1q complex.
DR   IntAct; P14106; 1.
DR   STRING; 10090.ENSMUSP00000040246; -.
DR   PhosphoSitePlus; P14106; -.
DR   SwissPalm; P14106; -.
DR   CPTAC; non-CPTAC-5579; -.
DR   PaxDb; P14106; -.
DR   PeptideAtlas; P14106; -.
DR   PRIDE; P14106; -.
DR   ProteomicsDB; 265398; -.
DR   Antibodypedia; 30104; 265 antibodies.
DR   Ensembl; ENSMUST00000046384; ENSMUSP00000040246; ENSMUSG00000036905.
DR   GeneID; 12260; -.
DR   KEGG; mmu:12260; -.
DR   UCSC; uc008vip.2; mouse.
DR   CTD; 713; -.
DR   MGI; MGI:88224; C1qb.
DR   eggNOG; ENOG502RYR2; Eukaryota.
DR   GeneTree; ENSGT00940000161091; -.
DR   HOGENOM; CLU_001074_0_2_1; -.
DR   InParanoid; P14106; -.
DR   OMA; YEPRNGK; -.
DR   OrthoDB; 1258047at2759; -.
DR   TreeFam; TF329591; -.
DR   Reactome; R-MMU-166663; Initial triggering of complement.
DR   Reactome; R-MMU-173623; Classical antibody-mediated complement activation.
DR   Reactome; R-MMU-977606; Regulation of Complement cascade.
DR   BioGRID-ORCS; 12260; 1 hit in 53 CRISPR screens.
DR   ChiTaRS; C1qb; mouse.
DR   PRO; PR:P14106; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; P14106; protein.
DR   Bgee; ENSMUSG00000036905; Expressed in stroma of bone marrow and 301 other tissues.
DR   Genevisible; P14106; MM.
DR   GO; GO:0005581; C:collagen trimer; IEA:UniProtKB-KW.
DR   GO; GO:0005602; C:complement component C1 complex; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; HDA:BHF-UCL.
DR   GO; GO:0098794; C:postsynapse; IGI:ARUK-UCL.
DR   GO; GO:0045202; C:synapse; IDA:ARUK-UCL.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0048839; P:inner ear development; IDA:MGI.
DR   GO; GO:0098883; P:synapse pruning; IGI:ARUK-UCL.
DR   Gene3D; 2.60.120.40; -; 1.
DR   InterPro; IPR001073; C1q_dom.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR037573; Complement_C1qB.
DR   InterPro; IPR008983; Tumour_necrosis_fac-like_dom.
DR   PANTHER; PTHR15427:SF18; PTHR15427:SF18; 1.
DR   Pfam; PF00386; C1q; 1.
DR   Pfam; PF01391; Collagen; 2.
DR   PRINTS; PR00007; COMPLEMNTC1Q.
DR   SMART; SM00110; C1Q; 1.
DR   SUPFAM; SSF49842; SSF49842; 1.
DR   PROSITE; PS50871; C1Q; 1.
PE   1: Evidence at protein level;
KW   Collagen; Complement pathway; Disulfide bond; Glycoprotein; Hydroxylation;
KW   Immunity; Innate immunity; Pyrrolidone carboxylic acid; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL          1..25
FT   CHAIN           26..253
FT                   /note="Complement C1q subcomponent subunit B"
FT                   /id="PRO_0000003522"
FT   DOMAIN          29..112
FT                   /note="Collagen-like"
FT   DOMAIN          115..253
FT                   /note="C1q"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00368"
FT   MOD_RES         26
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P02746"
FT   MOD_RES         33
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         36
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         39
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         51
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         54
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         57
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         60
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         63
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         75
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         81
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         84
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         90
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         96
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         99
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         108
FT                   /note="5-hydroxylysine"
FT                   /evidence="ECO:0000250"
FT   DISULFID        29
FT                   /note="Interchain (with C-26 in chain A)"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        115
FT                   /note="G -> R (in Ref. 1; CAA34757)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   253 AA;  26717 MW;  0F5C33EA2DE2E253 CRC64;
     MKTQWGEVWT HLLLLLLGFL HVSWAQSSCT GPPGIPGIPG VPGVPGSDGQ PGTPGIKGEK
     GLPGLAGDLG EFGEKGDPGI PGTPGKVGPK GPVGPKGTPG PSGPRGPKGD SGDYGATQKV
     AFSALRTINS PLRPNQVIRF EKVITNANEN YEPRNGKFTC KVPGLYYFTY HASSRGNLCV
     NLVRGRDRDS MQKVVTFCDY AQNTFQVTTG GVVLKLEQEE VVHLQATDKN SLLGIEGANS
     IFTGFLLFPD MDA
//
